Opposing Extracellular Signal-Regulated Kinase and Akt Pathways Control Schwann Cell Myelination
Open Access
- 28 July 2004
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 24 (30) , 6724-6732
- https://doi.org/10.1523/jneurosci.5520-03.2004
Abstract
Schwann cells are the myelinating glia of the peripheral nervous system, and their development is regulated by various growth factors, such as neuregulin, platelet-derived growth factor (PDGF), and insulin-like growth factor-I (IGF-I). However, the mechanism of intracellular signaling pathways following these ligand stimuli in Schwann cell differentiation remains elusive. Here, we demonstrate that in cultured Schwann cells, neuregulin and PDGF suppressed the expression of myelin-associated protein markers, whereas IGF-I promoted it. Although these ligands activated common downstream signaling pathways [i.e., extracellular signal-regulated kinase (Erk) and phosphatidylinositol-3-kinase (PI3K)-Akt pathways], the profiles of activation varied among ligands. To elucidate the function of these pathways and the mechanisms underlying Schwann cell differentiation, we used adenoviral vectors to selectively activate or inactivate these pathways. We found that the selective activation of Erk pathways suppressed Schwann cell differentiation, whereas that of PI3K pathways promoted it. Furthermore, lithium chloride, a modulator of glycogen synthase kinase-3β (GSK-3β) promoted Schwann cell differentiation, suggesting the involvement of GSK-3β as a downstream molecule of PI3K-Akt pathways. Selective activation of PI3K pathways in Schwann cells by gene transfer also demonstrated increased myelination in in vitro Schwann cell-DRG neuron cocultures and in vivo allogenic nerve graft experiments. We conclude that signals mediated by PI3K-Akt are crucial for initiation of myelination and that the effects of growth factors are primarily dependent on the balance between Erk and PI3K-Akt activation. Our results also propose the possibility of augmenting Schwann cell functions by modulating intracellular signals in light of future cell therapies.Keywords
This publication has 41 references indexed in Scilit:
- Influence of insulin‐like growth factor‐I (IGF‐I) on nerve autografts and tissue‐engineered nerve graftsMuscle & Nerve, 2002
- Signals that determine Schwann cell identity*Journal of Anatomy, 2002
- Fabricating autologous tissue to engineer artificial nerveMicrosurgery, 2002
- Akt Protein Kinase Inhibits Non-apoptotic Programmed Cell Death Induced by CeramideJournal of Biological Chemistry, 2002
- Lack of Replicative Senescence in Normal Rodent GliaScience, 2001
- The rapamycin-sensitive signal transduction pathway as a target for cancer therapyOncogene, 2000
- Partial Functional Recovery of Paraplegic Rat by Adenovirus-Mediated Gene Delivery of Constitutively Active MEK1Experimental Neurology, 2000
- Overexpression of Catalytic Subunit p110α of Phosphatidylinositol 3-Kinase Increases Glucose Transport Activity with Translocation of Glucose Transporters in 3T3-L1 AdipocytesJournal of Biological Chemistry, 1996
- Regulation of Rat Schwann Cell Po Expression and DNA Synthesis by Insulin‐like Growth Factors In VitroEuropean Journal of Neuroscience, 1996
- Requirement for Phosphatidylinositol-3 Kinase in the Prevention of Apoptosis by Nerve Growth FactorScience, 1995